Introduction
============

Autoimmune inner ear disease (AIED) is a rare, but rapidly progressive, bilateral form of sensorineural hearing loss (SNHL) ([@b1-mmr-20-01-0171]). Patients with AIED exhibit a loss of hearing over a period of weeks to months, often accompanied by tinnitus and vertigo, which may cause depressive thoughts and emotions, and disruption to daily activities and personal relationships for patients, ultimately affecting their quality of life ([@b2-mmr-20-01-0171],[@b3-mmr-20-01-0171]). However, this disease is reversible, and early diagnosis of AIED with timely administration of glucocorticoids may prevent damage to the inner ear structures and result in hearing preservation. Therefore, the investigation of rapid and reliable diagnostic biomarkers for AIED is an important field of clinical study.

Although the pathogenesis of AIED remains unclear, accumulating evidence suggests that activation of the innate immune system may be the primary contributor ([@b4-mmr-20-01-0171]). When an antigen enters the inner ear, it may be initially processed by the immunocompetent cells present in and around the endolymphatic sac. Through the secretion of various cytokines, these immunocompetent cells additionally stimulate migration of the inflammatory cells in the systemic circulation to the inner ear, subsequently amplifying the immune response and inducing more severe inner ear injuries ([@b4-mmr-20-01-0171]--[@b6-mmr-20-01-0171]). Therefore, several inflammatory cytokines, including tumor necrosis factor-α (TNF-α) ([@b7-mmr-20-01-0171]), interleukin-1β (IL-1β), Il-6, IL-17 ([@b8-mmr-20-01-0171]), C-X-C motif chemokine 10 (CXCL10) ([@b9-mmr-20-01-0171]) and interferon-γ (IFN-γ) ([@b10-mmr-20-01-0171]) have been suggested as biomarkers for the diagnosis of AIED. However, the implications of these biomarkers in a clinical setting remains limited and additional exploration of the key genes involved in the development of AIED is essential.

MicroRNAs (miRNAs) are endogenous, noncoding RNAs that have been demonstrated to serve an important role in regulating autoimmunity via binding to the 3′-untranslated region of their mRNA targets and thereby affecting the development of a number of autoimmune diseases ([@b11-mmr-20-01-0171]). For example, Ishida *et al* ([@b12-mmr-20-01-0171]) identified that the levels of miR-142-5p and miR-21 were significantly increased, whereas the level of miR-182 was significantly decreased, in experimental autoimmune uveoretinitis, and suggested that these miRNAs may participate in immunity by affecting the expression of IL-17. Fang *et al* ([@b13-mmr-20-01-0171]) demonstrated that the increased expression of miR-30a was associated with the development and progression of autoimmune encephalomyelitis. miR-30a increased the expression of pro-inflammatory IL-1β and inducible nitric oxide synthase in primary cultured mouse microglia. These data suggested that cytokine production and associated AIED may also be controlled by miRNAs. This hypothesis has been preliminarily supported by Rudnicki *et al* ([@b14-mmr-20-01-0171]) who demonstrated that inflammatory stimuli in the inner ear induced activation of the innate immune system via miR-224 and its target pentraxin 3. Furthermore, Xin *et al* ([@b15-mmr-20-01-0171]) also identified that compared with Fas(lpr/lpr) mice, a spontaneous AIED model accompanied by systemic lupus erythematosus, miR-155(−/-)Fas(lpr/lpr) mice exhibited decreased levels of total immunoglobulin (Ig)A, IgM and IgG and less infiltration of inflammatory cells in the kidney. In addition, the serum levels of IL-4 and IL-17a, secreted by T helper (Th)2 and Th17 cells, were decreased, and the cluster of differentiation (CD)4(+)/CD8(+) T cell ratio was restored in the miR-155(−/-)Fas(lpr/lpr) mice. These data implied that miR-155 may also be an important miRNA in the regulation of inflammation in AIED. However, the specific miRNAs that are involved in the development of AIED remain unclear. Therefore, the aim of the present study was to screen crucial serum miRNAs in an antigen-induced AIED mouse model.

Materials and methods
=====================

### Experimental animals

A total of 10 male adult (4 weeks) white guinea pigs weighing \~270 g and 54 female C57BL/6 4-week old mice weighing \~15 g (specific pathogen-free) were purchased from the Shanghai Laboratory Animal Center. Animals were housed in a temperature- (20--25°C) and humidity-controlled environment (40--70%). The animal procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals ([@b16-mmr-20-01-0171]) and were approved by the Institutional Animal Care and Use Committees of Shandong University (Jinan, China).

### Preparation of purified inner ear antigen

Following ether anesthesia, which was verified by the observation of muscle relaxation and loss of the pedal reflex with the presence of a normal heartbeat, guinea pigs were sacrificed by cardiac perfusion using cold PBS followed by cold 4% paraformaldehyde ([@b17-mmr-20-01-0171]). Animal death was defined as mydriasis and respiratory arrest. The temporal bones were obtained following decapitation, which were then placed in 10 mM sterile TBS supplemented with 1 µg/ml aprotinin to isolate the inner ear tissue. Following homogenization and centrifugation at 100,000 × g for 1 h at 4°C, the supernatant was separated and inner ear tissue antigen was prepared. The protein content was indirectly estimated by using a UV--Vis spectrophotometer at excitation and emission wavelengths of 260 and 280 nm, respectively (protein concentration =1.45 A280-0.74 A260) following sedimentation in TBS supplemented with 0.5% SDS, 0.5% mercaptoethanol, 1% glycerinum, 2 mM phenylmethylsulfonyl fluoride and 10 mM decyl maleic dimethylamine and centrifugation at 1,000 × g for 10 min at 4°C.

### Construction of an AIED animal model

The C57BL/6 mice were randomly assigned into three groups, including the control (n=18), immunization for 1 week (AIED-1; n=18) and immunization for 2 weeks (AIED-2; n=18) groups. Inner ear tissue antigen was emulsified with an equal volume of complete Freund\'s adjuvant (Sigma-Aldrich; Merck KGaA), which was subcutaneously injected (200 µl, containing 100 µg antigen) into multiple points in the neck and back of animals to induce AIED. In the control group, only complete Freund\'s adjuvant was injected. Injection sites were examined daily and reactogenicity was observed macroscopically ([@b18-mmr-20-01-0171]). Pain was evaluated by torsion observation and topical opioids ([@b19-mmr-20-01-0171]) were applied on the skin area if pain was present. All ulceration was observed macroscopically, and was spontaneously resolved without the requirement for treatment. The AIED model was confirmed by histopathological analysis of the cochlea via standard hematoxylin and eosin (H&E) staining: The cochlea tissue was fixed in 4% paraformaldehyde at 4°C for 3--5 days, dehydrated in graded ethanol (80, 90, 95, 100% ethanol I, 100% ethanol II and 100% ethanol III, 5 min each, at room temperature), cleared in xylene (I, II, each 30 min, at room temperature), embedded in paraffin (I, 1 h; II, 6 h; at 65°C) and sectioned to a thickness of 4 µm. Following deparaffinization and rehydration (xylene I 15 min, xylene II 15 min, 100% ethanol 5 min, 100% ethanol II 5 min, 95% ethanol 5 min, 80% ethanol 5 min, running water 1 min, at room temperature), the sections were stained with 0.5% hematoxylin and eosin for 5 min each at room temperature and then washed with distilled water. The slices were viewed under a light microscope (Olympus BX43; Olympus Corporation; magnification, ×200).

### Small RNAseq library preparation and sequencing

The serum samples of 3 AIED-1 and 3 control mice were obtained and subjected to miRNA deep sequencing analysis (LC Sciences). Briefly, total RNA was extracted from serum using TRIzol (Thermo Fisher Scientific, Inc.) and ligated to 3′ and RNA 5′ adapters of RNA at 70°C for 2 min each. The total RNA was reverse transcribed into cDNA using the SuperrScript II Reverse Transcriptase (Invitrogen; Thermo Fisher Scientific, Inc.) at 50°C for 1 h. PCR amplification was run with 25 µl reaction mixture, including 11.5 µl cDNA, 12.5 µl Phusion^®^ Hot Start Flex 2X Master Mix (New England Biolabs, Inc.) and 0.5 µl primers (each, 5′-GATCGGAAGAGCACACGTCTGAACTCCAGTCACAAGACGGAATCTCGTATGCCGTCTTCTGCTTG-3′; 5′-AGATCGGAAGAGCGTCGTGTAGGGAAAGA-3′). PCR amplification was carried out under conditions of 98°C for 3 sec followed by 12 cycles of 98°C for 10 sec, 60°C for 30 sec, and 72°C for 15 sec, and 72°C for 10 min. Small cDNA fractions were isolated by using 6% Tris-borate-EDTA/polyacrylamide gel electrophoresis (TBE-PAGE). Subsequently, the cDNA constructs were purified and the library was validated. Finally, the purified PCR products were used for sequencing analysis via the Illumina Solexa Sequencer (Illumina, Inc.). Raw sequencing reads were obtained using Illumina\'s Sequencing Control Studio software (v2.8; Illumina, Inc.).

### Data preprocessing

Preliminary quality control analysis of the FASTQ files was performed with FASTQC software (v0.10.0; <http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). Cutadapt (v1.1) ([@b20-mmr-20-01-0171]) was then used to trim 5′ (TGGAATTCTCGGGTGCCAAGG) and 3′ (GTTCAGAGTTCTACAGTCCGACG) adaptor sequences. Reads that were \<17 nucleotides following trimming were discarded. Trimmed reads were then additionally filtered using the FASTQC software.

### Quantification of miRNA gene expression

miRDeep software (v 2.0) ([@b21-mmr-20-01-0171]) was used to perform the qualitative and quantitative analysis for miRNAs. Briefly, the filtered 'clean reads' were aligned to mouse genome reference sequence (University of California Santa Cruz mm10) ([@b22-mmr-20-01-0171]) using the Mapper module in miRDeep2 software, which uses the bowtie algorithm. Then, the Quantifier module from the miRDeep2 package was used to generate miRNAs alignment files against known miRNAs from an miRNA database (miRBASE release 20) ([@b23-mmr-20-01-0171]). The novel miRNAs were predicted by the ViennaRNA (<https://www.tbi.univie.ac.at/RNA/>) ([@b24-mmr-20-01-0171]) and RNAFold ([@b25-mmr-20-01-0171]) algorithms from miRDeep2 package. The principal-component analysis (PCA) was performed using the 'Factoextra' package in R (v1.0.3) ([@b26-mmr-20-01-0171]) to examine the associations and variation between samples.

### Identification of differentially expressed miRNAs (DE-miRNAs)

The quantitative miRNAs data were normalized to read per million (RPM), which was calculated as RPM = miRNA counts / total counts of each sample × 1,000,000, and then log 2-transformed. The DE-miRNAs between the control and AIED groups were identified using a paired Student\'s t-test. miRNAs were considered to be differentially expressed at P\<0.05, fold change (FC) \>1.5 or \<1/1.5 and average expression \>(log~2~) 5 RPM. To determine whether the DE-miRNAs were able to differentiate AIED from control mice, clustering analysis ([@b27-mmr-20-01-0171]) was performed to generate a heat map using the hclust function implemented in the R package (v2.14.1; <http://www.R-project.org>), which uses the Euclidean distance and Ward\'s method.

### Target genes prediction of DE-miRNAs

miRNA target prediction was performed using the online software TargetScan Mouse (v7.1) ([@b28-mmr-20-01-0171]). The threshold value was set at Context Score \<-0.4. Then, the miRNA-target gene interaction network was constructed and visualized using Cytoscape software (v3.4; [www.cytoscape.org/](www.cytoscape.org/)) ([@b29-mmr-20-01-0171]).

### Functional enrichment analysis

To examine the underlying functions of target genes of DE-miRNAs, Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using the clusterProfiler package in R (v3.0.1) ([@b30-mmr-20-01-0171]) with the mouse annotations from package org.Mm.eg.db (v3.3.0) ([@b31-mmr-20-01-0171]) and KEGG.db (v2.2.11) ([@b32-mmr-20-01-0171]). P\<0.05 and multiple-adjusted P\<0.05 were set as the cut-off values.

### Statistical analysis

The data are expressed as mean ± standard deviation, and were analyzed by GraphPad Prism software (v6; GraphPad Software, Inc.). The DE-miRNAs between the control and AIED groups were identified using a paired Student\'s t-test. Comparisons between multiple groups were performed by one-way analysis of variance followed by Duncan\'s post-hoc test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### AIED model construction

In the control group, the hair of mice was smooth and glossy, and their body weight increased over time. However, in the inner ear tissue antigen immunization group, the activity of mice was decreased, with significantly decreased body weight after 1 week ([Fig. 1A](#f1-mmr-20-01-0171){ref-type="fig"}). In addition, slight ulceration, but no evidence of pain, was evident in the skin injected with the antigen. However, the ulcer scar was formed and then sloughed after 2 weeks, leading to a restored increase in the body weight in the AIED-2 group ([Fig. 1A](#f1-mmr-20-01-0171){ref-type="fig"}). These data suggest that the immune response was marked in the groups with inner ear tissue antigen immunization for 1 week and may have been sufficient to cause serious inner ears injuries. Subsequently, H&E staining was performed to observe the histopathological changes of the cochlea. As hypothesized, the inflammatory reactions in the inner ears of animals were evident in groups following immunization. Infiltration of inflammatory cells, primarily lymphocytes, was observed in the cochlear axis. The number of spiral ganglion cells was decreased and their distribution disordered. Shrinkage occurred in the organ of Corti, with a small level of necrosis observed in the outer hair cells. Vacuolar degeneration was occasionally visible in the hair cells of the cristae ampullaris ([Fig. 1B](#f1-mmr-20-01-0171){ref-type="fig"}). These changes were not present in the control mice, indicating that the AIED model was successfully established.

### Identification of miRNAs

Following quality control analysis, 3,060,225--13,477,582 clean reads were obtained for the small RNA library. The length distribution analysis indicated that the majority of the reads were between 19--24 nucleotides (nt) long, with the most common length being 22 nt ([Fig. 2](#f2-mmr-20-01-0171){ref-type="fig"}). The trimmed reads were aligned against the mouse genome reference sequence. As a result, 67.7--80.7% of reads were mapped perfectly to the mouse genome ([Table I](#tI-mmr-20-01-0171){ref-type="table"}), which were subsequently screened to identify known and novel miRNAs. Consequently, a total of 995 mature mouse miRNAs were identified and 337 novel miRNAs were annotated. PCA analysis ([Fig. 3A](#f3-mmr-20-01-0171){ref-type="fig"}) indicated that the known miRNAs clearly distinguished each AIED from each control sample, indicating there was there was a high level of consistency between samples.

### Screening of DE-miRNAs and prediction of their target genes

A total of 22 miRNAs were identified as DE-miRNAs between AIED and control mice based on the thresholds, including 10 upregulated and 12 downregulated genes ([Table II](#tII-mmr-20-01-0171){ref-type="table"}). The identified DE-miRNAs also significantly differentiated AIED from control samples according to the heat map presented in [Fig. 3B](#f3-mmr-20-01-0171){ref-type="fig"}.

Based on the TargetScan Mouse prediction, 1,958 genes were identified as the targets for the 22 DE-miRNAs. The number of target genes of each miRNA is demonstrated in [Fig. 4](#f4-mmr-20-01-0171){ref-type="fig"}. Then, a miRNA-mRNA interaction network was constructed, in which 1,696 genes and 22 miRNAs were included ([Fig. 5](#f5-mmr-20-01-0171){ref-type="fig"}).

### Functional enrichment analysis of target genes

Functional enrichment analysis was performed for all target genes to reveal their underlying functions. As a result, only the target genes of 8 miRNAs were enriched for GO terms (miR-10b-3p, let-7j, miR-1943-5p, miR-196b-5p, miR-338-3p, miR-455-5p, miR-8112 and miR-92b-3p; [Fig. 6](#f6-mmr-20-01-0171){ref-type="fig"}) and KEGG pathways (miR-10b-3p, let-7c-5p, let-7g-5p, let-7j, miR-181c-5p, miR-181d-5p, miR-222-3p and miR-8112; [Fig. 7](#f7-mmr-20-01-0171){ref-type="fig"}), amongst which miR-10b-3p, let-7j and miR-8112 were common in each group. The results ([Tables III](#tIII-mmr-20-01-0171){ref-type="table"} and [IV](#tIV-mmr-20-01-0171){ref-type="table"}) indicated that miR-10b-3p may be particularly important for AIED as its target genes included inflammatory chemokines \[including C-C motif chemokine (CCL) 12\]. miR-8112 may be involved in AIED by affecting factors within the Wnt signaling pathway, including Wnt9b, Wnt 3a and Wnt2b ([Tables III](#tIII-mmr-20-01-0171){ref-type="table"} and [IV](#tIV-mmr-20-01-0171){ref-type="table"}). The target genes of let-7j were enriched in Glycosphingolipid biosynthesis - lacto and neolacto series and Mucin type O-glycan biosynthesis pathways, including polypeptide N-acetylgalactosaminyltransferase (Galnt) 2 and Galnt12 ([Tables III](#tIII-mmr-20-01-0171){ref-type="table"} and [IV](#tIV-mmr-20-01-0171){ref-type="table"}); these 2 pathways are associated with glycosylation, and induce the activation of the immune response.

Discussion
==========

Previous studies have indicated that there are miRNA profiles associated with noise-induced hearing loss ([@b33-mmr-20-01-0171],[@b34-mmr-20-01-0171]), but the AIED-associated miRNAs remain undetermined. To the best of our knowledge, the present study investigated, for the first time, the serum miRNA profiles in AIED by constructing an AIED mouse model. The results identified 22 DE-miRNAs in the AIED mice compared with the control mice. The functions of 13 of these miRNAs were enriched, among which miR-10b-3p, miR-8112 and let-7j may be particularly important for the development of AIED, as suggested by the GO and KEGG pathway enrichment analysis of their target genes, in which they were predicted to affect chemokine signaling (miR-10b-3p-Ccl12), Wnt signaling (miR-8112-Wnt9b; miR-8112-wnt 3a and miR-8112-Wnt2b) and O-glycan biosynthesis pathways (let-7j-Galnt2a and let-7j-Galnt12). This appears to be in concordance with the previously identified inflammatory mechanisms of AIED ([@b4-mmr-20-01-0171]).

It has been suggested that miR-10b was significantly upregulated in ankylosing spondylitis ([@b35-mmr-20-01-0171]), which is a common autoimmune disease associated with the induction of SNHL ([@b36-mmr-20-01-0171]--[@b38-mmr-20-01-0171]). Therefore, miR-10b may also be hypothesized to be highly expressed in AIED, which was demonstrated in the present study (FC =1.54; P=0.04). However, Chen *et al* ([@b35-mmr-20-01-0171]) identified that miR-10b overexpression inhibited the production of IL-17A by total CD4 and differentiating Th17 cells, suggesting that miR-10b may likely constitute part of a negative feedback loop that restricts the enhanced inflammatory Th17 responses. Although these results appeared to be inconsistent with our data, they may be reasonable as the present study similarly predicted that miR-10b may downregulate CCL12, a known inflammatory chemokine ([@b39-mmr-20-01-0171]). Furthermore, it has been demonstrated that the use of the C-C chemokine receptor type 2 agonists, CCL2 and CCL12, elicited migration in Th17-polarized cells and additionally stimulated a modest enrichment of IL-17(+) cells ([@b40-mmr-20-01-0171]). Therefore, miR-10b may serve crucial roles in AIED by regulating CCL-12 mediated Th17 responses. However, additional exploration of the roles of miR-10b-3p in AIED is required, as the study conducted by Mojsilovic-Petrovic *et al* ([@b39-mmr-20-01-0171]) only examined the role of miR-10b-5p, although it may be inferred that miR-10b-3p may have a similar effect to miR-10b-5p ([@b41-mmr-20-01-0171]).

miR-8112 is a rarely studied miRNA involved in disease, with the exception of one study by Wang *et al* ([@b42-mmr-20-01-0171]), which indicated that miR-8112 was highly expressed in MC3T3-E1 cells exposed to high-dose fluoride and may induce the formation of impaired bone diseases, including skeletal fluorosis. Patients with skeletal fluorosis have also been demonstrated to exhibit varying degrees of hearing loss ([@b43-mmr-20-01-0171]). Therefore, miR-8112 was hypothesized to be upregulated in AIED, which was verified in the results of the present study (FC=1.82; P=0.02). Notably, the present study suggested that inhibition of Wnt signaling pathway genes (Wnt9b, Wnt 3a and Wnt2b) may be an underlying mechanism of miR-8112, which has not been demonstrated previously, to the best of our knowledge. This prediction may be indirectly supported by the observation that the loss of Wnt/β-catenin made hair cells more vulnerable to neomycin-induced injury and caused hearing loss ([@b44-mmr-20-01-0171]), while activation of Wnt/β-catenin markedly promoted the mitotic regeneration of new hair cells and attenuated neurodegeneration in the auditory cortex ([@b45-mmr-20-01-0171],[@b46-mmr-20-01-0171]). The association between the Wnt signaling pathway and AIED may also be associated with the inflammatory and oxidative stress, as the study by Liu *et al* ([@b44-mmr-20-01-0171]) indicated that loss of β-catenin in hair cells led to decreased expression of antioxidant enzymes.

The Let-7 miRNA family has been suggested to exert inhibitory effects on the inflammation. For example, Brennan *et al* ([@b47-mmr-20-01-0171]) observed that ectopic overexpression of let-7 inhibited the inflammatory responses including proliferation, migration, monocyte adhesion and NF-κB activation in vascular smooth muscle cells. In addition, Kumar *et al* ([@b48-mmr-20-01-0171]) demonstrated that exogenous administration of let-7 mimics decreased IL-13 levels and relieved allergic airway inflammation. In concordance with these studies, the present study identified that let-7j, let-7g-5p and let-7c-5p were also downregulated in AIED mice. In addition, subsequent analysis also revealed that let-7j may be involved in AIED by regulating Galnts. Galnts are enzymes responsible for initiating the cascade of mucin-type O-linked glycosylation for certain inflammation-associated proteins, including selectin ligands. Block *et al* ([@b49-mmr-20-01-0171]) demonstrated that compared with wild-type mice, L-selectin-dependent leukocyte rolling was completely abolished in Galnt1(−/-) mice, as its ligand was not able to be glycosylated by Galnt1. Although Galnt1 and Galnt12 have not been demonstrated in AIED, we hypothesized they may be upregulated by let-7j; however, this requires additional investigation.

In conclusion, the present study preliminarily revealed several important inflammatory-associated miRNAs, miR-10b-3p, miR-8112 and let-7j, in an AIED mouse model. They may be potential biomarkers and their abnormal expression may be conducive to early diagnosis of AIED and timely treatment with glucocorticoids. However, additional studies are required to confirm their diagnostic values using clinical samples and to investigate the direct interaction between these miRNAs and their target genes, including miR-10b-3p-Ccl12, miR-8112-Wnt9b/Wnt 3a/Wnt2b and let-7j-Galnt2/Galnt12.
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###### 

Quality control and alignment results.

  Sample   Raw reads     Following QC reads   Mapped reads   Mapped reads. %
  -------- ------------- -------------------- -------------- -----------------
  Case 1     8,827,017     3,060,225            2,070,930    67.7
  Case 2   12,375,221      9,365,942            6,493,558    69.3
  Case 3   11,975,356      8,136,614            5,522,291    67.9
  Ctrl 1   12,655,012      8,128,777            6,558,442    80.7
  Ctrl 2   17,988,328    13,477,582           10,106,224     75.0
  Ctrl 3   10,252,143      6,396,838            4,773,578    74.6

QC, quality control; Ctrl, control.

###### 

Differentially expressed miRNAs screened.

  miRNA             P-value   Fold change   Average expression (log~2~ RPM)
  ----------------- --------- ------------- ---------------------------------
  mmu-let-7j        0.018     −0.42         9.73
  mmu-miR-181c-5p   0.025     −0.45         8.12
  mmu-miR-340-3p    0.003     −0.48         3.14
  mmu-miR-181d-5p   0.007     −0.48         8.73
  mmu-miR-186-5p    0.013     −0.50         9.04
  mmu-miR-196b-5p   0.038     −0.55         6.05
  mmu-miR-455-5p    0.042     −0.56         7.58
  mmu-miR-338-3p    0.007     −0.60         6.42
  mmu-let-7g-5p     0.034     −0.62         13.41
  mmu-miR-140-5p    0.043     −0.62         9.82
  mmu-let-7c-5p     0.045     −0.63         11.67
  mmu-miR-222-3p    0.018     −0.65         11.19
  mmu-miR-10b-3p    0.044     1.54          3.83
  mmu-miR-34a-3p    0.024     1.57          2.56
  mmu-miR-92b-3p    0.001     1.62          7.53
  mmu-miR-1943-5p   0.020     1.71          4.11
  mmu-miR-532-3p    0.005     1.74          6.53
  mmu-miR-874-3p    0.011     1.76          4.74
  mmu-miR-8112      0.017     1.82          6.14
  mmu-miR-296-3p    0.014     2.17          5.59
  mmu-miR-1943-3p   0.006     2.41          2.51
  mmu-miR-511-3p    0.007     2.43          8.44

mmu, *Mus musculus*; miR, microRNA; RPM, read per million.

###### 

GO enrichment for the target genes of differentially expressed miRNAs.

  Cluster       ID           Description                                                                                                P-value      Adjusted P-value   Gene ID
  ------------- ------------ ---------------------------------------------------------------------------------------------------------- ------------ ------------------ ------------------------------------------------
  let-7j        GO:0016863   Intramolecular oxidoreductase activity, transposing C=C bonds                                              1.07×10^5^   2.99×10^3^         Hsd3b6, Hsd3b3, Hsd3b2
  let-7j        GO:0008378   Galactosyltransferase activity                                                                             1.20×10^4^   7.81×10^3^         B3gnt5, Galnt2, Fut9, Galnt12
  let-7j        GO:0008375   Acetylglucosaminyltransferase activity                                                                     2.42×10^4^   7.81×10^3^         B3gnt5, Galnt2, Fut9, Galnt12
  let-7j        GO:0033764   Steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor               3.63×10^4^   7.81×10^3^         Hsd3b6, Hsd3b3, Hsd3b2
  let-7j        GO:0016229   Steroid dehydrogenase activity                                                                             4.99×10^4^   7.81×10^3^         Hsd3b6, Hsd3b3, Hsd3b2
  miR-196b-5p   GO:0000978   RNA polymerase II core promoter proximal region sequence-specific DNA binding                              2.53×10^4^   2.42×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-196b-5p   GO:0000987   Core promoter proximal region sequence-specific DNA binding                                                3.44×10^4^   2.42×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-196b-5p   GO:0001159   Core promoter proximal region DNA binding                                                                  3.60×10^4^   2.42×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-196b-5p   GO:0000982   Transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding   3.76×10^4^   2.42×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-196b-5p   GO:0008201   Heparin binding                                                                                            5.62×10^4^   2.90×10^2^         Fgfbp3, Lxn, Prss57, Ecm2
  miR-455-5p    GO:0008766   UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate-D-alanyl-D-alanine ligase activity              9.11×10^4^   2.14×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-455-5p    GO:0018169   Ribosomal S6-glutamic acid ligase activity                                                                 9.11×10^4^   2.14×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-455-5p    GO:0043773   Coenzyme F420-0 gamma-glutamyl ligase activity                                                             9.11×10^4^   2.14×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-455-5p    GO:0043774   Coenzyme F420-2 alpha-glutamyl ligase activity                                                             9.11×10^4^   2.14×10^2^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-455-5p    GO:0070735   Protein-glycine ligase activity                                                                            9.11×10^4^   2.14×10^2^         Fgfbp3, Lxn, Prss57, Ecm2
  miR-338-3p    GO:0005096   GTPase activator activity                                                                                  1.76×10^4^   1.76×10^4^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-338-3p    GO:0030695   GTPase regulator activity                                                                                  2.94×10^4^   2.94×10^4^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-338-3p    GO:0005088   Ras guanyl-nucleotide exchange factor activity                                                             3.44×10^4^   3.44×10^4^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-338-3p    GO:0005089   Rho guanyl-nucleotide exchange factor activity                                                             4.38×10^4^   4.38×10^4^         Nr6a1, Hoxa7, Otx1, Hoxa5, Hand1, Sarnp
  miR-338-3p    GO:0051082   Unfolded protein binding                                                                                   4.88×10^4^   4.88×10^4^         Fgfbp3, Lxn, Prss57, Ecm2
  miR-10b-3p    GO:0001106   RNA polymerase II transcription corepressor activity                                                       4.20×10^3^   3.67×10^3^         76365
  miR-10b-3p    GO:0043175   RNA polymerase core enzyme binding                                                                         4.20×10^3^   4.20×10^3^         Rprd1b
  miR-10b-3p    GO:0048020   CCR chemokine receptor binding                                                                             5.59×10^3^   5.59×10^3^         Ccl12
  miR-10b-3p    GO:0008009   Chemokine activity                                                                                         6.81×10^3^   6.81×10^3^         Ccl12
  miR-10b-3p    GO:0042379   Chemokine receptor binding                                                                                 8.73×10^3^   8.73×10^3^         Ccl12
  miR-92b-3p    GO:0008198   Ferrous iron binding                                                                                       5.34×10^4^   5.34×10^4^         Isca1, 432732
  miR-92b-3p    GO:0051537   2 iron, 2 sulfur cluster binding                                                                           6.84×10^4^   6.84×10^4^         Isca1, 432732
  miR-92b-3p    GO:0004364   Glutathione transferase activity                                                                           9.74×10^4^   9.74×10^4^         Gsta2, Gm10639
  miR-92b-3p    GO:0051539   4 iron, 4 sulfur cluster binding                                                                           1.62×10^3^   1.62×10^3^         Isca1, 432732
  miR-1943-5p   GO:0030374   Ligand-dependent nuclear receptor transcription coactivator activity                                       1.57×10^5^   1.57×10^5^         Atxn7l3, Usp22, 15361, Actn2; Hmga1-rs1, Rbm14
  miR-8112      GO:0005109   Frizzled binding                                                                                           1.14×10^5^   1.14×10^5^         Ror2, Wnt9b, Wnt3a, Wnt2b

GO, Gene ontology.

###### 

Kyoto Encyclopedia of Genes and Genomes pathway enrichment for the target genes of differentially expressed miRNAs..

  Cluster       ID         Description                                                             P-value      Adjusted P-value   Gene ID
  ------------- ---------- ----------------------------------------------------------------------- ------------ ------------------ ---------------------------------------------
  let-7j        mmu00601   Glycosphingolipid biosynthesis - lacto and neolacto series              2.85×10^3^   4.75×10^2^         B3gnt5, Fut9
  let-7j        mmu00512   Mucin type O-glycan biosynthesis                                        3.06×10^3^   4.75×10^2^         Galnt2, Galnt12
  miR-181c-5p   mmu00250   Alanine, aspartate and glutamate metabolism                             1.37×10^2^   4.53×10^2^         Gfpt1
  miR-181c-5p   mmu00520   Amino sugar and nucleotide sugar metabolism                             1.81×10^2^   4.53×10^2^         Gfpt1
  miR-181d-5p   mmu00250   Alanine, aspartate and glutamate metabolism                             1.37×10^2^   4.53×10^2^         Gfpt1
  miR-181d-5p   mmu00520   Amino sugar and nucleotide sugar metabolism                             1.81×10^2^   4.53×10^2^         Gfpt1
  let-7g-5p     mmu04550   Signaling pathways regulating pluripotency of stem cells                6.84×10^5^   6.57×10^3^         Smarcad1, Skil, Wnt16, Hand1, Hoxb1, Acvr1c
  let-7g-5p     mmu00280   Valine, leucine and isoleucine degradation                              1.92×10^4^   9.22×10^3^         Agxt2, Bcat1, Ehhadh, Acat1
  let-7c-5p     mmu04550   Signaling pathways regulating pluripotency of stem cells                5.95×10^5^   5.59×10^3^         Smarcad1, Skil, Wnt16, Hand1, Hoxb1, Acvr1c
  miR-222-3p    mmu04727   GABAergic synapse                                                       6.35×10^4^   2.35×10^2^         Gng5, Gabra1, Gnb3
  miR-222-3p    mmu05032   Morphine addiction                                                      7.23×10^4^   2.35×10^2^         Gng5, Gabra1, Gnb3
  miR-222-3p    mmu04724   Glutamatergic synapse                                                   1.35×10^3^   2.92×10^2^         Gng5, Ppp3r1, Gnb3
  miR-222-3p    mmu04371   Apelin signaling pathway                                                2.38×10^3^   3.85×10^2^         Agtr1a, Gng5, Gnb3
  miR-222-3p    mmu04723   Retrograde endocannabinoid signaling                                    2.96×10^3^   3.85×10^2^         Gng5, Gabra1, Gnb3
  miR-222-3p    mmu04151   PI3K-Akt signaling pathway                                              4.02×10^3^   4.36×10^2^         Ddit4, Gng5, Gnb3, Kit
  miR-10b-3p    mmu05144   Malaria                                                                 6.08×10^3^   2.68×10^2^         Ccl12
  miR-10b-3p    mmu05323   Rheumatoid arthritis                                                    1.03×10^2^   2.68×10^2^         Ccl12
  miR-10b-3p    mmu04657   IL-17 signaling pathway                                                 1.13×102     2.68×102^4^        Ccl12
  miR-10b-3p    mmu04933   AGE-RAGE signaling pathway in diabetic complications                    1.24×10^2^   2.68×10^2^         Ccl12
  miR-10b-3p    mmu05142   Chagas disease (American trypanosomiasis)                               1.26×10^2^   2.68×10^2^         Ccl12
  miR-10b-3p    mmu04668   TNF signaling pathway                                                   1.34×10^2^   2.68×10^2^         Ccl12
  miR-10b-3p    mmu05418   Fluid shear stress and atherosclerosis                                  1.76×10^2^   2.78×10^2^         Ccl12
  miR-10b-3p    mmu04621   NOD-like receptor signaling pathway                                     2.08×10^2^   2.78×10^2^         Ccl12
  miR-10b-3p    mmu05164   Influenza A                                                             2.08×10^2^   2.78×10^2^         Ccl12
  miR-10b-3p    mmu04062   Chemokine signaling pathway                                             2.42×10^2^   2.90×10^2^         Ccl12
  miR-10b-3p    mmu05168   Herpes simplex infection                                                2.67×10^2^   2.91×10^2^         Ccl12
  miR-10b-3p    mmu04060   Cytokine-cytokine receptor interaction                                  3.36×10^2^   3.36×10^2^         Ccl12
  miR-8112      mmu04150   mTOR signaling pathway                                                  1.40×10^2^   8.55×10^4^         Fzd8, Clip1, Wnt9b, Wnt3a, Wnt2b, Lpin1
  miR-8112      mmu05217   Basal cell carcinoma                                                    4.06×10^5^   1.24×10^3^         Fzd8, Wnt9b, Wnt3a, Wnt2b
  miR-8112      mmu04916   Melanogenesis                                                           4.17×10^4^   8.48×10^3^         Fzd8, Wnt9b, Wnt3a, Wnt2b
  miR-8112      mmu04550   Signaling pathways regulating pluripotency of stem cells                1.36×10^3^   1.60×10^2^         Fzd8, Wnt9b, Wnt3a, Wnt2b
  miR-8112      mmu05224   Breast cancer                                                           1.64×10^3^   1.60×10^2^         Fzd8, Wnt9b, Wnt3a, Wnt2b
  miR-8112      mmu04310   Wnt signaling pathway                                                   1.72×10^3^   1.60×10^2^         Fzd8, Wnt9b, Wnt3a, Wnt2b
  miR-8112      mmu04390   Hippo signaling pathway                                                 2.10×10^3^   1.60×10^2^         Fzd8, Wnt9b, Wnt3a, Wnt2b
  miR-8112      mmu00532   Glycosaminoglycan biosynthesis - chondroitin sulfate/dermatan sulfate   2.28×10^3^   1.60×10^2^         Chst15, B3galt6
  miR-8112      mmu05200   Pathways in cancer                                                      2.36×10^3^   1.60×10^2^         Fzd8, Wnt9b, Lpar1, Wnt3a, Wnt2b, Bcr
  miR-8112      mmu04974   Protein digestion and absorption                                        3.98×10^3^   2.43×10^2^         Col2a1, Atp1a2, Col11a1
  miR-8112      mmu05205   Proteoglycans in cancer                                                 5.96×10^3^   3.30×10^2^         Fzd8; Wnt9b, Wnt3a, Wnt2b

miR, microRNA; mmu, *Mus musculus*.
